MedTrace Logo

Evaluation of the Curative Effect of Ru-Yi-Jin-Huang-Saan

NCT05638360 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and safety of Ru-Yi-Jin-Huang-Saan for the treatment of Colles' fracture.

Conditions

  • Colles' Fracture

Interventions

DRUG

Ru Yi Jin Huang Powder

Each patch contains 13g Ru Yi Jin Huang Powder and 10c.c. water.

DRUG

Placebo

Each patch contains 13g starch and 10c.c. water.

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • LienCheng Lin, Master · Changhua Christian Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-06-30
Completion
2025-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638360 on ClinicalTrials.gov